RGS:NASDAQRegis Corporation Analysis
Data as of 2026-04-28 - not real-time
$27.85
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Regis Corporation (RGS) is trading at $27.85, just below its calculated resistance of $28.31 and comfortably above the support level of $23.56. The 20‑day SMA (25.78) sits above the 50‑day SMA (23.95), while the 200‑day SMA (25.18) is slightly lower, indicating a modest short‑term bullish bias. Technical momentum is reinforced by a bullish MACD histogram (+0.17) and a rising volume trend, though the RSI of 66 signals the stock is approaching overbought territory. Volatility is elevated at roughly 46% over the past 30 days, and the beta (≈0.74) suggests moderate market sensitivity.
Fundamentally, RGS appears dramatically cheap with a trailing PE of 0.62, price‑to‑book of 0.37, and price‑to‑sales of 0.30, alongside a stellar ROE near 94% and 22% YoY revenue growth. However, the balance sheet is a concern: a debt‑to‑equity ratio of 182% and net debt far exceeding cash, coupled with a negative forward EPS and forward PE of –10.5, point to earnings pressure ahead. The company pays no dividend, and the consumer‑cyclical nature of the hair‑care segment adds sectoral sensitivity.
Fundamentally, RGS appears dramatically cheap with a trailing PE of 0.62, price‑to‑book of 0.37, and price‑to‑sales of 0.30, alongside a stellar ROE near 94% and 22% YoY revenue growth. However, the balance sheet is a concern: a debt‑to‑equity ratio of 182% and net debt far exceeding cash, coupled with a negative forward EPS and forward PE of –10.5, point to earnings pressure ahead. The company pays no dividend, and the consumer‑cyclical nature of the hair‑care segment adds sectoral sensitivity.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and SMA crossover
- RSI approaching overbought levels
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- Strong revenue growth and high ROE
- Extremely low valuation multiples
- Potential upside if debt is managed
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Heavy debt load and negative forward earnings
- Consumer‑cyclical exposure
- Lack of dividend and high price volatility
Key Metrics & Analysis
Financial Health
Revenue Growth22.30%
Profit Margin50.79%
P/E Ratio0.6
ROE94.31%
ROA2.60%
Debt/Equity182.32
P/B Ratio0.4
Op. Cash Flow$16.9M
Free Cash Flow$6.7M
Technical Analysis
TrendNeutral
RSI66.0
Support$23.56
Resistance$28.31
MA 20$25.78
MA 50$23.95
MA 200$25.18
MACDBullish
VolumeIncreasing
Fear & Greed Index89.25
Valuation
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.74
Volatility46.00%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.